icon-folder.gif   Conference Reports for NATAP  
 
  ID Week
October 2-6, 2013
San Francisco
Back grey_arrow_rt.gif
 
 
 
Long-Term Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Compared to Efavirenz/Emtricitabine/Tenofovir DF in HIV-1-Infected, Treatment-Na´ve, Black Versus Non-Black Subjects
 
 
  Reported by Jules Levin
IDSA Oct 2-6 2013 San Francisco, CA
 
D Hardy1, P Ruane2, K Workowski3, P Shalit4, G Crofoot5, T Nguyen6, H Liu6, M Rhee6, D Piontkowsky6, and J Szwarcberg6
1David Geffen School of Medicine at UCLA, Los Angeles, CA; 2Peter J. Ruane, MD, Inc., Los Angeles, CA; 3Emory University, Atlanta, GA; 4Peter Shalit, MD, Seattle, WA; 5Gordon E. Crofoot, MD, Houston, TX; 6Gilead Sciences Inc., Foster City, CA

ID1.gif

ID2.gif

ID3.gif

ID4.gif

ID5.gif

ID6.gif

ID7.gif

ID8.gif

ID9.gif

ID10.gif

ID11.gif